During the past decade, Regional Oncology Dispensary conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Regional Oncology Dispensary" are "Lung Cancer" (1 trials) and "Metastatic/Recurrent Breast Cancer" (1 trials). Many other conditions were trialed in "Regional Oncology Dispensary" in a lesser frequency.

Most popular intervention types in "Regional Oncology Dispensary" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Motexafin Gadolinium" (1 trials) and "Tesmilifene (YMB 1002)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Regional Oncology Dispensary" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Regional Oncology Dispensary". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Regional Oncology Dispensary, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Regional Oncology Dispensary, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".